Reviews Ribavirin


No reviews yet.

Copegus Drug Description
COPEGUS®
(ribavirin, USP) Tablets


COPEGUS (ribavirin) monotherapy is not effective for the treatment of chronic
hepatitis C virus infection and should not be used alone for this indication
(see WARNINGS).
The primary clinical toxicity of ribavirin is hemolytic anemia. The anemia
associated with ribavirin therapy may result in worsening of cardiac disease
that has led to fatal and nonfatal myocardial infarctions. Patients with a history
of significant or unstable cardiac disease should not be treated with ribavirin
(see WARNINGS, ADVERSE REACTIONS, and DOSAGE AND ADMINISTRATION).
Significant teratogenic and/or embryocidal effects have been demonstrated
in all animal species exposed to ribavirin. In addition, ribavirin has a multiple
dose half-life of 12 days, and it may persist in non-plasma compartments for
as long as 6 months. Ribavirin therapy is contraindicated in women who are pregnant
and in the male partners of women who are pregnant. Extreme care must be taken
to avoid pregnancy during therapy and for 6 months after completion of therapy
in both female patients and in female partners of male patients who are taking
ribavirin therapy. At least two reliable forms of effective contraception must
be utilized during treatment and during the 6-month posttreatment follow-up
period (see CONTRAINDICATIONS, WARNINGS, and PATIENT INFORMATION,
and PRECAUTIONS: Pregnancy: Category X).

DRUG DESCRIPTION



What are the possible side effects of ribavirin (Copegus, Rebetol, RibaPak, Ribasphere, RibaTab)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using ribavirin and call your doctor at once if you have any of these serious side effects:

pale or yellowed skin, dark colored urine, easy bruising or bleeding, confusion, or unusual weakness;
severe depression, hallucinations, thoughts of suicide or hurting yourself;
...
Read All Potential Side Effects for Copegus »




COPEGUS, ribavirin, is a nucleoside analogue with antiviral activity. The chemical
name of ribavirin is 1-β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
and has the following structural formula:








The empirical formula of ribavirin is C8H12N4O5
and the molecular weight is 244.2. Ribavirin is a white to off-white powder.
It is freely soluble in water and slightly soluble in anhydrous alcohol.
COPEGUS (ribavirin) is available as a light pink to pink colored, flat, oval-shaped, film-coated tablet for oral administration. Each tablet contains 200 mg of ribavirin and the following inactive ingredients: pregelatinized starch, microcrystalline cellulose, sodium starch glycolate, cornstarch, and magnesium stearate. The coating of the tablet contains Chromatone-P® or Opadry® Pink (made by using hydroxypropyl methyl cellulose, talc, titanium dioxide, synthetic yellow iron oxide, and synthetic red iron oxide), ethyl cellulose (ECD-30), and triacetin.
Mechanism of Action
Ribavirin is a synthetic nucleoside analogue. The mechanism by which the combination of ribavirin and an interferon product exerts its effects against the hepatitis C virus has not been fully established.
Last reviewed on RxList: 7/1/2010




Copegus Drug Description
COPEGUS®
(ribavirin, USP) Tablets


COPEGUS (ribavirin) monotherapy is not effective for the treatment of chronic
hepatitis C virus infection and should not be used alone for this indication
(see WARNINGS).
The primary clinical toxicity of ribavirin is hemolytic anemia. The anemia
associated with ribavirin therapy may result in worsening of cardiac disease
that has led to fatal and nonfatal myocardial infarctions. Patients with a history
of significant or unstable cardiac disease should not be treated with ribavirin
(see WARNINGS, ADVERSE REACTIONS, and DOSAGE AND ADMINISTRATION).
Significant teratogenic and/or embryocidal effects have been demonstrated
in all animal species exposed to ribavirin. In addition, ribavirin has a multiple
dose half-life of 12 days, and it may persist in non-plasma compartments for
as long as 6 months. Ribavirin therapy is contraindicated in women who are pregnant
and in the male partners of women who are pregnant. Extreme care must be taken
to avoid pregnancy during therapy and for 6 months after completion of therapy
in both female patients and in female partners of male patients who are taking
ribavirin therapy. At least two reliable forms of effective contraception must
be utilized during treatment and during the 6-month posttreatment follow-up
period (see CONTRAINDICATIONS, WARNINGS, and PATIENT INFORMATION,
and PRECAUTIONS: Pregnancy: Category X).

DRUG DESCRIPTION



What are the possible side effects of ribavirin (Copegus, Rebetol, RibaPak, Ribasphere, RibaTab)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using ribavirin and call your doctor at once if you have any of these serious side effects:

pale or yellowed skin, dark colored urine, easy bruising or bleeding, confusion, or unusual weakness;
severe depression, hallucinations, thoughts of suicide or hurting yourself;
...
Read All Potential Side Effects for Copegus »




COPEGUS, ribavirin, is a nucleoside analogue with antiviral activity. The chemical
name of ribavirin is 1-β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
and has the following structural formula:








The empirical formula of ribavirin is C8H12N4O5
and the molecular weight is 244.2. Ribavirin is a white to off-white powder.
It is freely soluble in water and slightly soluble in anhydrous alcohol.
COPEGUS (ribavirin) is available as a light pink to pink colored, flat, oval-shaped, film-coated tablet for oral administration. Each tablet contains 200 mg of ribavirin and the following inactive ingredients: pregelatinized starch, microcrystalline cellulose, sodium starch glycolate, cornstarch, and magnesium stearate. The coating of the tablet contains Chromatone-P® or Opadry® Pink (made by using hydroxypropyl methyl cellulose, talc, titanium dioxide, synthetic yellow iron oxide, and synthetic red iron oxide), ethyl cellulose (ECD-30), and triacetin.
Mechanism of Action
Ribavirin is a synthetic nucleoside analogue. The mechanism by which the combination of ribavirin and an interferon product exerts its effects against the hepatitis C virus has not been fully established.
Last reviewed on RxList: 7/1/2010




Copegus Drug Description
COPEGUS®
(ribavirin, USP) Tablets


COPEGUS (ribavirin) monotherapy is not effective for the treatment of chronic
hepatitis C virus infection and should not be used alone for this indication
(see WARNINGS).
The primary clinical toxicity of ribavirin is hemolytic anemia. The anemia
associated with ribavirin therapy may result in worsening of cardiac disease
that has led to fatal and nonfatal myocardial infarctions. Patients with a history
of significant or unstable cardiac disease should not be treated with ribavirin
(see WARNINGS, ADVERSE REACTIONS, and DOSAGE AND ADMINISTRATION).
Significant teratogenic and/or embryocidal effects have been demonstrated
in all animal species exposed to ribavirin. In addition, ribavirin has a multiple
dose half-life of 12 days, and it may persist in non-plasma compartments for
as long as 6 months. Ribavirin therapy is contraindicated in women who are pregnant
and in the male partners of women who are pregnant. Extreme care must be taken
to avoid pregnancy during therapy and for 6 months after completion of therapy
in both female patients and in female partners of male patients who are taking
ribavirin therapy. At least two reliable forms of effective contraception must
be utilized during treatment and during the 6-month posttreatment follow-up
period (see CONTRAINDICATIONS, WARNINGS, and PATIENT INFORMATION,
and PRECAUTIONS: Pregnancy: Category X).

DRUG DESCRIPTION



What are the possible side effects of ribavirin (Copegus, Rebetol, RibaPak, Ribasphere, RibaTab)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using ribavirin and call your doctor at once if you have any of these serious side effects:

pale or yellowed skin, dark colored urine, easy bruising or bleeding, confusion, or unusual weakness;
severe depression, hallucinations, thoughts of suicide or hurting yourself;
...
Read All Potential Side Effects for Copegus »




COPEGUS, ribavirin, is a nucleoside analogue with antiviral activity. The chemical
name of ribavirin is 1-β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
and has the following structural formula:








The empirical formula of ribavirin is C8H12N4O5
and the molecular weight is 244.2. Ribavirin is a white to off-white powder.
It is freely soluble in water and slightly soluble in anhydrous alcohol.
COPEGUS (ribavirin) is available as a light pink to pink colored, flat, oval-shaped, film-coated tablet for oral administration. Each tablet contains 200 mg of ribavirin and the following inactive ingredients: pregelatinized starch, microcrystalline cellulose, sodium starch glycolate, cornstarch, and magnesium stearate. The coating of the tablet contains Chromatone-P® or Opadry® Pink (made by using hydroxypropyl methyl cellulose, talc, titanium dioxide, synthetic yellow iron oxide, and synthetic red iron oxide), ethyl cellulose (ECD-30), and triacetin.
Mechanism of Action
Ribavirin is a synthetic nucleoside analogue. The mechanism by which the combination of ribavirin and an interferon product exerts its effects against the hepatitis C virus has not been fully established.
Last reviewed on RxList: 7/1/2010




Copegus Drug Description
COPEGUS®
(ribavirin, USP) Tablets


COPEGUS (ribavirin) monotherapy is not effective for the treatment of chronic
hepatitis C virus infection and should not be used alone for this indication
(see WARNINGS).
The primary clinical toxicity of ribavirin is hemolytic anemia. The anemia
associated with ribavirin therapy may result in worsening of cardiac disease
that has led to fatal and nonfatal myocardial infarctions. Patients with a history
of significant or unstable cardiac disease should not be treated with ribavirin
(see WARNINGS, ADVERSE REACTIONS, and DOSAGE AND ADMINISTRATION).
Significant teratogenic and/or embryocidal effects have been demonstrated
in all animal species exposed to ribavirin. In addition, ribavirin has a multiple
dose half-life of 12 days, and it may persist in non-plasma compartments for
as long as 6 months. Ribavirin therapy is contraindicated in women who are pregnant
and in the male partners of women who are pregnant. Extreme care must be taken
to avoid pregnancy during therapy and for 6 months after completion of therapy
in both female patients and in female partners of male patients who are taking
ribavirin therapy. At least two reliable forms of effective contraception must
be utilized during treatment and during the 6-month posttreatment follow-up
period (see CONTRAINDICATIONS, WARNINGS, and PATIENT INFORMATION,
and PRECAUTIONS: Pregnancy: Category X).

DRUG DESCRIPTION



What are the possible side effects of ribavirin (Copegus, Rebetol, RibaPak, Ribasphere, RibaTab)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using ribavirin and call your doctor at once if you have any of these serious side effects:

pale or yellowed skin, dark colored urine, easy bruising or bleeding, confusion, or unusual weakness;
severe depression, hallucinations, thoughts of suicide or hurting yourself;
...
Read All Potential Side Effects for Copegus »




COPEGUS, ribavirin, is a nucleoside analogue with antiviral activity. The chemical
name of ribavirin is 1-β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
and has the following structural formula:








The empirical formula of ribavirin is C8H12N4O5
and the molecular weight is 244.2. Ribavirin is a white to off-white powder.
It is freely soluble in water and slightly soluble in anhydrous alcohol.
COPEGUS (ribavirin) is available as a light pink to pink colored, flat, oval-shaped, film-coated tablet for oral administration. Each tablet contains 200 mg of ribavirin and the following inactive ingredients: pregelatinized starch, microcrystalline cellulose, sodium starch glycolate, cornstarch, and magnesium stearate. The coating of the tablet contains Chromatone-P® or Opadry® Pink (made by using hydroxypropyl methyl cellulose, talc, titanium dioxide, synthetic yellow iron oxide, and synthetic red iron oxide), ethyl cellulose (ECD-30), and triacetin.
Mechanism of Action
Ribavirin is a synthetic nucleoside analogue. The mechanism by which the combination of ribavirin and an interferon product exerts its effects against the hepatitis C virus has not been fully established.
Last reviewed on RxList: 7/1/2010




Copegus Drug Description
COPEGUS®
(ribavirin, USP) Tablets


COPEGUS (ribavirin) monotherapy is not effective for the treatment of chronic
hepatitis C virus infection and should not be used alone for this indication
(see WARNINGS).
The primary clinical toxicity of ribavirin is hemolytic anemia. The anemia
associated with ribavirin therapy may result in worsening of cardiac disease
that has led to fatal and nonfatal myocardial infarctions. Patients with a history
of significant or unstable cardiac disease should not be treated with ribavirin
(see WARNINGS, ADVERSE REACTIONS, and DOSAGE AND ADMINISTRATION).
Significant teratogenic and/or embryocidal effects have been demonstrated
in all animal species exposed to ribavirin. In addition, ribavirin has a multiple
dose half-life of 12 days, and it may persist in non-plasma compartments for
as long as 6 months. Ribavirin therapy is contraindicated in women who are pregnant
and in the male partners of women who are pregnant. Extreme care must be taken
to avoid pregnancy during therapy and for 6 months after completion of therapy
in both female patients and in female partners of male patients who are taking
ribavirin therapy. At least two reliable forms of effective contraception must
be utilized during treatment and during the 6-month posttreatment follow-up
period (see CONTRAINDICATIONS, WARNINGS, and PATIENT INFORMATION,
and PRECAUTIONS: Pregnancy: Category X).

DRUG DESCRIPTION



What are the possible side effects of ribavirin (Copegus, Rebetol, RibaPak, Ribasphere, RibaTab)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using ribavirin and call your doctor at once if you have any of these serious side effects:

pale or yellowed skin, dark colored urine, easy bruising or bleeding, confusion, or unusual weakness;
severe depression, hallucinations, thoughts of suicide or hurting yourself;
...
Read All Potential Side Effects for Copegus »




COPEGUS, ribavirin, is a nucleoside analogue with antiviral activity. The chemical
name of ribavirin is 1-β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
and has the following structural formula:








The empirical formula of ribavirin is C8H12N4O5
and the molecular weight is 244.2. Ribavirin is a white to off-white powder.
It is freely soluble in water and slightly soluble in anhydrous alcohol.
COPEGUS (ribavirin) is available as a light pink to pink colored, flat, oval-shaped, film-coated tablet for oral administration. Each tablet contains 200 mg of ribavirin and the following inactive ingredients: pregelatinized starch, microcrystalline cellulose, sodium starch glycolate, cornstarch, and magnesium stearate. The coating of the tablet contains Chromatone-P® or Opadry® Pink (made by using hydroxypropyl methyl cellulose, talc, titanium dioxide, synthetic yellow iron oxide, and synthetic red iron oxide), ethyl cellulose (ECD-30), and triacetin.
Mechanism of Action
Ribavirin is a synthetic nucleoside analogue. The mechanism by which the combination of ribavirin and an interferon product exerts its effects against the hepatitis C virus has not been fully established.
Last reviewed on RxList: 7/1/2010





Other reviews about Ribavirin on wordpress

Buy Ribavirin Online Order Cheap Ribavirin Generic Purchase Discount Without Prescription
  by worlddnews
FOLLOW THIS LINK FOR ENTER TO TRUSTED & REPUTABLE ONLINE DRUGSTORE WHERE YOU CAN GET ALL QUALIFIED INFORMATION ABOUT Ribavirin ONLINE     This shows that diabetes could thing then the […]


Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C
  by JOC
Source: Alimentary Pharmacology & Therapeutics Volume 16 Issue 9 Page 1623  - September 2002 C. H. Chang*, K. Y. Chen*, M. Y. Lai*† & K. A. Chan‡ SUMMARY Aim: […]


Leading article - Treating HCV with ribavirin analogues and ribavirin-like molecules
  by JOC
Source: Journal of Antimicrob. Chemotherapy Jan 2006 vol.57 N.1 p.8-13 Robert G. Gish* California Pacific Medical Center, Liver Transplant Program, Division of Hepatology and Complex GI, 2340 Clay Street, […]


Goodbye Ribavirin?
  by Sans
OKAYAMA, Japan (UPI) -- Japanese scientists say they`ve found statins, typically used as anti-cholesterol medications, can inhibit the replication of the hepatitis C virus. The findings mean statins might […]


Goodbye Ribavirin?
  by Sans
OKAYAMA, Japan (UPI) -- Japanese scientists say they`ve found statins, typically used as anti-cholesterol medications, can inhibit the replication of the hepatitis C virus.The findings mean statins might […]


Peginterferon Alfa-2a and Ribavirin in Latino and Non-Latino Whites with Hepatitis C
  by journaldokter
Peginterferon Alfa-2a and Ribavirin in Latino and Non-Latino Whites with Hepatitis C Maribel Rodriguez-Torres, M.D., Lennox J. Jeffers, M.D., Muhammad Y. Sheikh, M.D., Lorenzo Rossaro, M.D., Victor Ankoma-Sey, M.D., […]


Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
  by journaldokter
Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon Adrian M. Di Bisceglie, M.D., Mitchell L. Shiffman, M.D., Gregory T. Everson, M.D., Karen L. Lindsay, M.D., James E. […]


PROSTATE DRUG: Common anti-viral drug can help some patients
  by Jim Tucker
MAY 15: SCIENCE DAILY: A ground-breaking Canada-wide clinical trial has shown that a common anti-viral drug, ribavirin, can be beneficial in the treatment of cancer patients, including prostate. The […]


New York Reports Its First Swine Flu Death, May 17, 2009, assistant principal, New York City public school, Mitchell Wiener, experimental drug, Ribavirin, overwhelmed by the illness
  by citizenwells
From the NY Times, May 17, 2009: "New York Reports Its First Swine Flu Death" "An assistant principal at a New York City public school died of complications from swine […]


More encouraging news for the future of MS!!!
  by sofija
This news is also taken from Medical News Today (dated Aug. 15th 2009), which states the source as coming from "Hard to Treat Diseases Inc."... and it relates to […]



Other reviews about Ribavirin on web:

Ribavirin (brand names: Copegus, Rebetol, Ribasphere, Vilona and Virazole) is an anti-viral drug indicated for severe RSV infection (individually), hepatitis C infection (used ... Ribavirin - Wikipedia, the free encyclopedia


Accurate, FDA approved Ribavirin information for healthcare professionals and patients - brought to you by Drugs.com. Ribavirin Official FDA information, side effects and uses.


Ribavirin will not treat hepatitis C (a virus that infects the liver and may cause severe liver damage or liver cancer) unless it is taken with another medication. Ribavirin: MedlinePlus Drug Information


ribavirin n. A synthetic antiviral ribonucleoside, C 8 H 12 N 4 O 5 , that inhibits the replication of DNA and RNA, used to treat respiratory ribavirin: Definition from Answers.com


All about Ribavirin Tablets. View complete and up to date Ribavirin information - part of the Drugs.com trusted medication database. Ribavirin Tablets Facts and Comparisons at Drugs.com


Learn about the prescription medication Rebetol (Ribavirin), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Rebetol (Ribavirin) Drug Information: Uses, Side Effects, Drug ...


Ribavirin is a powerful antiviral drug treatment for hepatitis C. Here is information on side effects, cost, effectiveness and warnings. Ribavirin - Ribavirin Drug and Treatment for Hepatitis


Ribavirin is a nucleoside analog antiviral medicine that is used in combination with interferon to treat chronic hepatitis C infection. Side effects and interactions are available ... Ribavirin - drugstore.com. Low prices, side effects, interactions.


Learn more about Ribavirin. Find the Web's best health guides, medical reports, news, videos and tools for Ribavirin. Share Ribavirin experiences and get advice from experts. Ribavirin Overview - References, Advice, News, Videos, Coping ...


Ribavirin has many side effects. Here are the most common side effects when treating hepatitis C with ribavirin and interferon. Ribavirin Side Effects - What Are Ribavirin Side Effects





Featured Reviews

Reviews Vitamin A, D, C, and Fluoride

Triple Vita Drops with Fluoride Drug Description Triple Vita Drops with Fluoride 0.25 mg DRUG DESCRIPTION Each 1.0 mL supplies: Percentage of U. S. Recommended Daily Allowance Infants Children Under Age 4 Years ...
Read More  |  Review This
Reviews Removed from US Market)

Propulsid Drug Description WARNING Serious cardiac arrhythmias including ventricular tachycardia, ventricular fibrillation, torsades de pointes, and QT prolongation have been reported in patients taking cisapride. Many of these patients also...
Read More  |  Review This
Reviews Keppra

Keppra Drug Description KEPPRA® (levetiracetam) 250 mg, 500 mg, 750 mg, and 1000 mg Tablets and 100 mg/mL Oral Solution DRUG DESCRIPTION What are the possible side effects of levetiracetam (Keppra, Keppra XR)? Get emergency...
Read More  |  Review This
Reviews Econazole Nitrate

Spectazole Drug Description SPECTAZOLE (econazole nitrate) Cream DRUG DESCRIPTION What are the possible side effects of econazole topical (Spectazole)? Serious side effects of econazole topical topical use are unexpected. Stop...
Read More  |  Review This
Reviews Oraqix

Oraqix Drug Description Oraqix® (lidocaine and prilocaine periodontal) Gel 2.5% / 2.5% DRUG DESCRIPTION Oraqix® (lidocaine and prilocaine periodontal gel,) 2.5%/2.5% is a microemulsion in which the oil phase is a eutectic mixture...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....